What's breaking now, across thousands of outlets.
→ Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer, effective Aug. 18. DiNapoli formerly worked at Genentech and led ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Children growing up without a father in the home during their first year may experience earlier signs of puberty. A recent study published in the Biology of Sex Differences suggests early family…
Exclusive: Of 224 branded infant foods and snacks, more than half are in breach of guidelines brought in a year ago Almost a quarter of popular branded baby foods sold in UK supermarkets still contain…
Two Republican lawmakers are asking the FDA to reject clinical data from China unless a trial site has been recently audited by the agency, and to institute a sweeping review of existing products’…
